SBIR/STTR Research Award
OTHER FUNCTION: Anti- NPRA Inhibitors Targeting Cancer Stem Cells in Tumoroids
Award amount
$224,999Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TRANSGENEX NANOBIOTECH, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CNWNKZL5QXM1
- Solicitation number
- Not reported
- Topic code
- NCI
Research abstract
Not Available
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER
- IGF OT IGF TRANSGENEX NANOBIOTECH INC
- IGF::OT::IGF
- SBIR Ph I Topic 314 Fibrous Scaffold-induced Spheroids Mimicking TME
- Targeting of Curcumin-genistein nanocomplexes for Treatment of Prostate Cancer
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
11 SBIR/STTR records share this UEI (2004–2017). Reported award amounts total $3,908,648. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense